Respiratory Review of 2014: Asthma.
10.4046/trd.2014.77.6.237
- Author:
Ho Il YOON
1
Author Information
1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. dextro70@gmail.com
- Publication Type:Review
- Keywords:
Asthma;
Eosinophilia;
Cytokines;
Sublingual ImmunotherapyPatients
- MeSH:
Asthma*;
Cytokines;
Eosinophilia;
Eosinophils;
Humans;
Inflammation;
Phenotype;
Sublingual Immunotherapy
- From:Tuberculosis and Respiratory Diseases
2014;77(6):237-242
- CountryRepublic of Korea
- Language:English
-
Abstract:
Asthma is a chronic inflammatory disease of the airway that comprises a variety of etiologies and inflammatory phenotypes. Clinically, there is a wide range of patients with varying severities and responses to individual drugs. The introduction of inhaled corticosteroid therapy has dramatically changed the treatment of asthma. Recent development of new therapies suggests the possibility of another breakthrough. These can be categorized as follows: anti-cytokine therapies that usually target eosinophilic inflammation, sublingual immunotherapy, and bronchial thermoplasty. In this paper, we will review the major articles related to asthma treatment that were published in 2013.